Saturday, July 11, 2026

pharma · Helicobacter Pylori · Type 2 Diabetes

Shandong Jinpharm Co.,Ltd

Shandong University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Helicobacter Pylori, Type 2 Diabetes, Sedation. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and

Linyi, CN HQ
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Linyi, CN
Employees
5
Programs
3
Drugs
5
Patents
0
Clinical program

placebo

Approved · small molecule · Sedation

placebo for Sedation is a Approved program (small_molecule) at Shandong University with 1 ClinicalTrials.gov record(s).

← All Shandong University projects Approved small molecule active

Internal code 2020SDU-QILU-021

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Shandong University
Phase
Approved
Modality
small_molecule
Indication
Sedation
Status
active
Trials
1

Clinical trials